Antonio Daniele Pinna
University of Bologna
602 Papers
3.8K Citations
Antonio Daniele Pinna is an academic researcher from University of Bologna. The author has contributed to research in topics: Transplantation & Liver transplantation. The author has an hindex of 71, co-authored 589 publications. Previous affiliations of Antonio Daniele Pinna include San Antonio River Authority & ISMETT.
Chat about Author
Papers
Patent
Treatment of hepatitis C by administration of anti-IL-2 receptor monoclonal antibody
Antonio Daniele Pinna,Camillo Ricordi,Andreas G. Tzakis +2 more
- 29 Oct 1999
TL;DR: A novel method using anti-interleukin 2 receptor monoclonal antibodies for treating patients having severe viral hepatitis C is described in this paper, which may be used to treat recurrent hepatitis C following liver transplantation, thereby reducing complications in recipients of liver allografts.
Application of a fluorescent PCR method for molecular diagnosis of posttransplant lymphoproliferative disorders on routine tissue sections.
Elisa Gruppioni,Barbara Corti,Annalisa Altimari,Elena Gabusi,Emanuele Panza,Gian Luca Grazi,Antonio Daniele Pinna,De Ruvo N,Michelangelo Fiorentino,Walter F. Grigioni,Antonia D’Errico Grigioni +10 more
TL;DR: This rapid and straightforward procedure, which allows identification of a wide range of IgH rearrangements, could facilitate molecular analysis of PTLD in routine practice, while limiting consumption of valuable diagnostic material.
Retransplantation (Causes, Outcome)
Valentina Rosa Bertuzzo,Giorgio Ercolani,Matteo Cescon,Antonio Daniele Pinna +3 more
- 01 Jan 2015
TL;DR: Orthotopic liver transplantation is the treatment of choice for end-stage liver failure, although with the improvement in technical and medical skills, some transplanted patients experience graft failure and require retransplantation (re-OLT).
Relative Survival Instead of Overall Survival Should Be Used as Outcome When Analyzing the Effect of Age After Treatment of Hepatocellular Carcinoma.
TL;DR: The results of a prospective phase II multicenter trial-the eastern cooperative oncology group (E2202) study and an international consensus on standardization of data collection for complications associated with esophagectomy are published.